Portola Pharmaceuticals
Therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€1.3b (Public information from May 2020)
San Francisco California (HQ)
Authorizing premium user...